A Medicare program designed to save money and make things easier for their beneficiaries with diabetes actually appears to have increased costs, increased hospitalizations, and even increased deaths.
The Centers for Medicare and Medicaid Services claims the program for diabetes testing supplies poses no health threat. However, a peer-reviewed journal article recently published in Diabetes Care (fee for full article access) shows otherwise (press release (3/2016)), (press release (12/2015, includes a free link to the white paper the published article is based on)).
The image above is just a snippet of a great infographic from the Diabetes Patient Advocacy Coalition (DPAC) about this issue.
DPAC has assembled a resource page to help you better understand the competitive bidding problem and learn more about what you can do about it. DPAC also recently hosted the article’s author, Dr. Gary A. Puckrein, for an “Ask the Expert” webinar session where he describes the situation in great detail (watch the recording).
To put this all in a nutshell, when you start making treatment decisions outside of the doctor/patient relationship, it hurts people. Our government needs to call for the suspension of this dangerous program until safety measures can be put in place.
When you start making treatment decisions outside of the doctor/patient relationship, it hurts people.
DPAC has made it very easy to learn more and to let your representatives know how your feel.
This will take time and continued effort. Please don’t doubt the value of your voice to your representative. If you have diabetes or love someone with diabetes, please act now and help stop this dangerous program (it will take less than two minutes of your time).
We need every voice. We need your voice.
The Medicare Competitive Bidding Program must be suspended until a full and complete investigation can be completed and we know that people with diabetes are safe.
